Tenet Healthcare Corporation is a diversified healthcare services company headquartered in Dallas with 110,000 employees. Through an expansive care network that includes United Surgical Partners International, we operate 65 hospitals and approximately 550 other healthcare facilities, including surgical hospitals, ambulatory surgery centers, urgent care and imaging centers and other care sites and clinics. Tenet Healthcare Corporation also operates Conifer Health Solutions, which provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve.
Company profile
Ticker
THC
Exchange
Website
CEO
Ronald Rittenmeyer
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
NATIONAL MEDICAL ENTERPRISES INC /NV/
SEC CIK
Corporate docs
Subsidiaries
601 N 30th Street I, L.L.C. • 601 N 30th Street II, L.L.C. • 601 N 30th Street III, Inc. • Abrazo Health Network EP Clinical Services, LLC • Advantage Health Care Management Company, LLC • AHM Acquisition Co., Inc. • Alvarado Hospital Medical Center, Inc. • AMC/North Fulton Urgent Care #1, L.L.C. • AMC/North Fulton Urgent Care #3, L.L.C. • AMC/North Fulton Urgent Care #4, L.L.C. ...
IRS number
952557091
THC stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-K
2022 FY
Annual report
17 Feb 23
8-K
Provides 2023 Financial Outlook
9 Feb 23
8-K
Tenet Anticipates Beating Midpoint of Latest 2022 Outlook; Announces Key Leadership Updates
19 Jan 23
10-Q
2022 Q3
Quarterly report
28 Oct 22
8-K
Announces $1 Billion Share Repurchase Program
20 Oct 22
8-K
Departure of Directors or Certain Officers
3 Oct 22
S-8
Registration of securities for employees
15 Aug 22
10-Q
2022 Q2
Quarterly report
29 Jul 22
8-K
Reaffirms 2022 Adjusted EBITDA Outlook
21 Jul 22
8-K
Entry into a Material Definitive Agreement
15 Jun 22
Transcripts
THC
Earnings call transcript
2022 Q4
9 Feb 23
THC
Earnings call transcript
2022 Q3
21 Oct 22
THC
Earnings call transcript
2022 Q2
22 Jul 22
THC
Earnings call transcript
2022 Q1
21 Apr 22
THC
Earnings call transcript
2021 Q4
8 Feb 22
THC
Earnings call transcript
2021 Q3
21 Oct 21
THC
Earnings call transcript
2021 Q2
22 Jul 21
THC
Earnings call transcript
2021 Q1
21 Apr 21
THC
Earnings call transcript
2020 Q4
10 Feb 21
THC
Earnings call transcript
2020 Q3
21 Oct 20
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 858.00 mm | 858.00 mm | 858.00 mm | 858.00 mm | 858.00 mm | 858.00 mm |
| Cash burn (monthly) | 116.67 mm | 125.50 mm | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 345.09 mm | 371.21 mm | n/a | n/a | n/a | n/a |
| Cash remaining | 512.91 mm | 486.79 mm | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 4.4 | 3.9 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
| 13F holders | Current |
|---|---|
| Total holders | 359 |
| Opened positions | 77 |
| Closed positions | 73 |
| Increased positions | 128 |
| Reduced positions | 111 |
| 13F shares | Current |
|---|---|
| Total value | 4.91 tn |
| Total shares | 105.86 mm |
| Total puts | 2.81 mm |
| Total calls | 2.09 mm |
| Total put/call ratio | 1.3 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 11.30 mm | $551.52 bn |
| BLK Blackrock | 10.15 mm | $495.10 bn |
| Glenview Capital Management | 8.90 mm | $434.04 bn |
| Harris Associates L P | 5.46 mm | $266.56 bn |
| IVZ Invesco | 4.18 mm | $203.77 bn |
| Camber Capital Management | 4.00 mm | $192.91 bn |
| FMR | 3.25 mm | $158.45 bn |
| STT State Street | 3.05 mm | $148.69 bn |
| Assenagon Asset Management | 1.96 mm | $95.42 mm |
| Canyon Capital Advisors | 1.87 mm | $91.03 bn |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Mar 23 | Thomas W Arnst | Common Stock | Sell | Dispose S | No | No | 60.07 | 1,600 | 96.11 k | 21,178 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Payment of exercise | Dispose F | No | No | 59.29 | 7,686 | 455.70 k | 33,006 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Option exercise | Acquire M | No | No | 0 | 25,854 | 0.00 | 40,692 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Payment of exercise | Dispose F | No | No | 59.29 | 2,124 | 125.93 k | 14,838 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Option exercise | Acquire M | No | No | 0 | 5,396 | 0.00 | 16,962 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Payment of exercise | Dispose F | No | No | 59.29 | 1,117 | 66.23 k | 11,566 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,838 | 0.00 | 12,683 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Payment of exercise | Dispose F | No | No | 60.62 | 829 | 50.25 k | 9,845 |
| 6 Mar 23 | Paola M Arbour | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,106 | 0.00 | 10,674 |
| 6 Mar 23 | Paola M Arbour | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 25,854 | 0.00 | 0 |
News
David Einhorn Sees 'Increasingly Difficult' Environment For Stocks, But He's Betting On These 3 'Ridiculously Inexpensive' Names
1 Mar 23
Stephens & Co. Maintains Equal-Weight on Tenet Healthcare, Raises Price Target to $64
22 Feb 23
Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $68
17 Feb 23
Mizuho Maintains Buy on Tenet Healthcare, Raises Price Target to $78
17 Feb 23
12 Health Care Stocks Moving In Tuesday's After-Market Session
14 Feb 23
Press releases
Tenet Reports Fourth Quarter and FY 2022 Results; Provides 2023 Financial Outlook
9 Feb 23
USPI and Providence Expand Partnership with a New Development Agreement
8 Feb 23
USPI Facilities Recognized for Excellence in Patient Experience
30 Jan 23
Tenet Anticipates Beating Midpoint of Latest 2022 Outlook; Announces Key Leadership Updates
19 Jan 23